rs1036914

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006180.6(NTRK2):​c.1397-37796A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.347 in 152,112 control chromosomes in the GnomAD database, including 9,740 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.35 ( 9740 hom., cov: 33)

Consequence

NTRK2
NM_006180.6 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.589

Publications

1 publications found
Variant links:
Genes affected
NTRK2 (HGNC:8032): (neurotrophic receptor tyrosine kinase 2) This gene encodes a member of the neurotrophic tyrosine receptor kinase (NTRK) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Signalling through this kinase leads to cell differentiation. Mutations in this gene have been associated with obesity and mood disorders. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
NTRK2 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 58
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • obesity, hyperphagia, and developmental delay
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_006180.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.479 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006180.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NTRK2
NM_006180.6
MANE Select
c.1397-37796A>G
intron
N/ANP_006171.2
NTRK2
NM_001018064.3
c.1397-43999A>G
intron
N/ANP_001018074.1Q548C2
NTRK2
NM_001369532.1
c.1397-43999A>G
intron
N/ANP_001356461.1Q16620-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NTRK2
ENST00000277120.8
TSL:1 MANE Select
c.1397-37796A>G
intron
N/AENSP00000277120.3Q16620-4
NTRK2
ENST00000323115.11
TSL:1
c.1361-43999A>G
intron
N/AENSP00000314586.5A0A8J8YUT9
NTRK2
ENST00000304053.11
TSL:1
c.1397-43999A>G
intron
N/AENSP00000306167.7Q16620-3

Frequencies

GnomAD3 genomes
AF:
0.347
AC:
52728
AN:
151994
Hom.:
9725
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.485
Gnomad AMI
AF:
0.219
Gnomad AMR
AF:
0.320
Gnomad ASJ
AF:
0.335
Gnomad EAS
AF:
0.316
Gnomad SAS
AF:
0.322
Gnomad FIN
AF:
0.259
Gnomad MID
AF:
0.345
Gnomad NFE
AF:
0.288
Gnomad OTH
AF:
0.362
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.347
AC:
52774
AN:
152112
Hom.:
9740
Cov.:
33
AF XY:
0.345
AC XY:
25635
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.485
AC:
20111
AN:
41488
American (AMR)
AF:
0.319
AC:
4881
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.335
AC:
1162
AN:
3470
East Asian (EAS)
AF:
0.316
AC:
1638
AN:
5180
South Asian (SAS)
AF:
0.321
AC:
1550
AN:
4824
European-Finnish (FIN)
AF:
0.259
AC:
2745
AN:
10582
Middle Eastern (MID)
AF:
0.344
AC:
101
AN:
294
European-Non Finnish (NFE)
AF:
0.289
AC:
19610
AN:
67966
Other (OTH)
AF:
0.368
AC:
777
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1747
3494
5240
6987
8734
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
504
1008
1512
2016
2520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.315
Hom.:
1043
Bravo
AF:
0.359
Asia WGS
AF:
0.384
AC:
1332
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
8.0
DANN
Benign
0.58
PhyloP100
-0.59
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1036914;
hg19: chr9-87438159;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.